Biotechnology
The Biotechnology industry has a total of 600 stocks, with a combined market cap of $1.1 trillion and total revenue of $105.29 billion.
Market Cap
1.1T
Revenue
105.29B
Profits
-41.72B
PE Ratio
n/a
Profit Margin
-39.62%
Dividend Yield
0.05%
600 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 116.59B | -0.93% | 42,135 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 81.88B | 0.19% | 61,045 | 14.25B |
| 3 | ARGX | argenx SE | 49.38B | -1.38% | 47,773 | 3.68B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 48.84B | -7.18% | 370,517 | 3.21B |
| 5 | ONC | BeOne Medicines AG | 36.96B | -1.15% | 24,625 | 4.97B |
| 6 | INSM | Insmed Incorporated | 36.12B | -3.76% | 114,971 | 447.02M |
| 7 | BNTX | BioNTech SE | 25.19B | 0.55% | 49,014 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 23.20B | 0.07% | 172,620 | 2.35B |
| 9 | RVMD | Revolution Medicines, Inc. | 22.20B | -3.20% | 373,196 | - |
| 10 | GMAB | Genmab A/S | 20.92B | -1.46% | 80,501 | 3.85B |
| 11 | INCY | Incyte Corporation | 20.62B | -1.72% | 60,866 | 4.81B |
| 12 | ROIV | Roivant Sciences Ltd. | 15.15B | -0.89% | 166,147 | 20.33M |
| 13 | SMMT | Summit Therapeutics Inc. | 14.50B | -4.47% | 405,670 | - |
| 14 | BBIO | BridgeBio Pharma, Inc. | 14.40B | -3.24% | 199,439 | 353.78M |
| 15 | MRNA | Moderna, Inc. | 13.15B | -1.90% | 908,081 | 2.23B |
| 16 | IONS | Ionis Pharmaceuticals, Inc. | 12.81B | -1.52% | 35,463 | 966.96M |
| 17 | ASND | Ascendis Pharma A/S | 12.13B | -2.61% | 169,142 | 758.59M |
| 18 | EXEL | Exelixis, Inc. | 11.78B | -0.66% | 356,922 | 2.29B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.54B | -1.17% | 7,858 | 740.64M |
| 20 | BMRN | BioMarin Pharmaceutical Inc. | 11.14B | -1.61% | 55,772 | 3.09B |
| 21 | RNA | Avidity Biosciences, Inc. | 10.90B | -0.06% | 77,939 | 20.87M |
| 22 | TECH | Bio-Techne Corporation | 10.34B | 0.99% | 21,373 | 1.22B |
| 23 | JAZZ | Jazz Pharmaceuticals plc | 9.86B | 0.72% | 17,220 | 4.16B |
| 24 | ABVX | ABIVAX Société Anonyme | 8.96B | 11.33% | 2,408,019 | 6.23M |
| 25 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.93B | 1.81% | 239,183 | 829.45M |
| 26 | AXSM | Axsome Therapeutics, Inc. | 8.80B | 3.08% | 73,680 | 561.26M |
| 27 | HALO | Halozyme Therapeutics, Inc. | 8.48B | -0.54% | 2,863 | 1.24B |
| 28 | NUVL | Nuvalent, Inc. | 7.91B | -3.01% | 21,545 | - |
| 29 | PRAX | Praxis Precision Medicines, Inc. | 7.72B | -2.41% | 29,896 | 7.46M |
| 30 | CAI | Caris Life Sciences, Inc. | 7.71B | -4.17% | 171,954 | 649.06M |
| 31 | CYTK | Cytokinetics, Incorporated | 7.58B | -0.82% | 55,444 | 87.21M |
| 32 | KRYS | Krystal Biotech, Inc. | 7.56B | -0.31% | 272 | 373.16M |
| 33 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.74B | -0.02% | 22,381 | 174.33M |
| 34 | KYMR | Kymera Therapeutics, Inc. | 5.98B | - | 4,724 | 43.74M |
| 35 | PTCT | PTC Therapeutics, Inc. | 5.96B | -4.20% | 277,639 | 1.78B |
| 36 | PCVX | Vaxcyte, Inc. | 5.96B | -1.19% | 30,040 | - |
| 37 | BLTE | Belite Bio, Inc | 5.94B | - | 61 | - |
| 38 | CRNX | Crinetics Pharmaceuticals, Inc. | 5.40B | -1.05% | 50,506 | 1.54M |
| 39 | COGT | Cogent Biosciences, Inc. | 5.33B | -0.91% | 122,976 | - |
| 40 | CRSP | CRISPR Therapeutics AG | 5.30B | 3.27% | 244,978 | 38.34M |
| 41 | IMVT | Immunovant, Inc. | 5.25B | -0.42% | 59,575 | - |
| 42 | APGE | Apogee Therapeutics, Inc. | 5.14B | -2.38% | 18,897 | - |
| 43 | PTGX | Protagonist Therapeutics, Inc. | 4.96B | -1.17% | 28,428 | 209.22M |
| 44 | CELC | Celcuity Inc. | 4.79B | -3.78% | 13,004 | - |
| 45 | GPCR | Structure Therapeutics Inc. | 4.78B | 0.72% | 17,459 | - |
| 46 | CGON | CG Oncology, Inc. | 4.50B | 2.94% | 168,288 | 2.17M |
| 47 | FOLD | Amicus Therapeutics, Inc. | 4.42B | - | 1,591,573 | 598.70M |
| 48 | ACAD | ACADIA Pharmaceuticals Inc. | 4.40B | -2.84% | 317 | 1.05B |
| 49 | MIRM | Mirum Pharmaceuticals, Inc. | 4.30B | -3.94% | 71,472 | 471.79M |
| 50 | LEGN | Legend Biotech Corporation | 4.27B | -2.10% | 118,675 | 909.05M |
| 51 | SRRK | Scholar Rock Holding Corporation | 4.23B | -1.66% | 29,299 | - |
| 52 | ADMA | ADMA Biologics, Inc. | 4.16B | -2.67% | 70,073 | 488.56M |
| 53 | LGND | Ligand Pharmaceuticals Incorporated | 4.09B | 0.58% | 626 | 251.23M |
| 54 | TGTX | TG Therapeutics, Inc. | 4.08B | -1.90% | 138,051 | 531.90M |
| 55 | CORT | Corcept Therapeutics Incorporated | 3.98B | 0.83% | 34,820 | 741.17M |
| 56 | NAMS | NewAmsterdam Pharma Company N.V. | 3.81B | -2.36% | 19,072 | 35.24M |
| 57 | TERN | Terns Pharmaceuticals, Inc. | 3.78B | -2.06% | 118,130 | - |
| 58 | ACLX | Arcellx, Inc. | 3.72B | -2.88% | 16,117 | 35.90M |
| 59 | VKTX | Viking Therapeutics, Inc. | 3.57B | -1.22% | 245,665 | - |
| 60 | ARQT | Arcutis Biotherapeutics, Inc. | 3.43B | -0.89% | 136,268 | 317.93M |
| 61 | VERA | Vera Therapeutics, Inc. | 3.42B | -1.06% | 23,375 | - |
| 62 | XENE | Xenon Pharmaceuticals Inc. | 3.26B | - | 10,917 | 7.50M |
| 63 | TARS | Tarsus Pharmaceuticals, Inc. | 3.25B | -0.34% | 7,650 | 366.10M |
| 64 | BEAM | Beam Therapeutics Inc. | 3.22B | 18.48% | 574,546 | 55.70M |
| 65 | IDYA | IDEAYA Biosciences, Inc. | 3.21B | -1.95% | 45,715 | 214.83M |
| 66 | CNTA | Centessa Pharmaceuticals plc | 3.21B | -2.01% | 21,709 | 15.00M |
| 67 | APLS | Apellis Pharmaceuticals, Inc. | 3.18B | -7.95% | 543,892 | 1.02B |
| 68 | LQDA | Liquidia Corporation | 3.12B | 0.03% | 285,702 | 69.22M |
| 69 | VRDN | Viridian Therapeutics, Inc. | 3.01B | -0.63% | 33,511 | 70.79M |
| 70 | TVTX | Travere Therapeutics, Inc. | 2.99B | -3.24% | 93,606 | 435.83M |
| 71 | IRON | Disc Medicine, Inc. | 2.94B | -0.18% | 20,829 | - |
| 72 | DYN | Dyne Therapeutics, Inc. | 2.88B | -1.41% | 51,740 | - |
| 73 | ADPT | Adaptive Biotechnologies Corporation | 2.79B | 15.80% | 565,350 | 252.75M |
| 74 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.76B | -1.32% | 65,782 | 578.20M |
| 75 | DNLI | Denali Therapeutics Inc. | 2.69B | 0.88% | 30,357 | - |
| 76 | RCUS | Arcus Biosciences, Inc. | 2.60B | 0.19% | 26,502 | 240.00M |
| 77 | EWTX | Edgewise Therapeutics, Inc. | 2.59B | -1.89% | 10,622 | - |
| 78 | AAPG | Ascentage Pharma Group International | 2.58B | - | 25 | 54.52M |
| 79 | WVE | Wave Life Sciences Ltd. | 2.56B | 1.08% | 155,869 | 109.23M |
| 80 | RXRX | Recursion Pharmaceuticals, Inc. | 2.55B | 5.26% | 2,512,743 | 43.69M |
| 81 | MLYS | Mineralys Therapeutics, Inc. | 2.55B | -3.57% | 23,895 | - |
| 82 | TLX | Telix Pharmaceuticals Limited | 2.53B | - | 9,092 | 664.23M |
| 83 | OCUL | Ocular Therapeutix, Inc. | 2.53B | 5.51% | 720,364 | 55.78M |
| 84 | SRPT | Sarepta Therapeutics, Inc. | 2.49B | -0.25% | 126,918 | 2.41B |
| 85 | MESO | Mesoblast Limited | 2.44B | -9.83% | 22,308 | 17.20M |
| 86 | ALMS | Alumis Inc. | 2.44B | 2.25% | 404,983 | 22.12M |
| 87 | SYRE | Spyre Therapeutics, Inc. | 2.40B | 0.95% | 25,554 | - |
| 88 | NUVB | Nuvation Bio Inc. | 2.38B | -13.56% | 1,699,796 | 26.75M |
| 89 | IBRX | ImmunityBio, Inc. | 2.33B | 1.50% | 1,001,255 | 82.56M |
| 90 | SLNO | Soleno Therapeutics, Inc. | 2.31B | -0.12% | 509,439 | 98.68M |
| 91 | HRMY | Harmony Biosciences Holdings, Inc. | 2.25B | 1.27% | 22,520 | 825.94M |
| 92 | IMNM | Immunome, Inc. | 2.24B | -3.61% | 104,390 | 9.68M |
| 93 | OLMA | Olema Pharmaceuticals, Inc. | 2.23B | 0.96% | 45,758 | - |
| 94 | RARE | Ultragenyx Pharmaceutical Inc. | 2.19B | 0.98% | 91,857 | 630.60M |
| 95 | GLPG | Galapagos NV | 2.17B | -0.06% | 10,043 | 336.64M |
| 96 | ZLAB | Zai Lab Limited | 2.02B | -1.86% | 44,138 | 441.63M |
| 97 | AUPH | Aurinia Pharmaceuticals Inc. | 1.99B | -0.40% | 31,668 | 265.81M |
| 98 | VCEL | Vericel Corporation | 1.95B | - | 92 | 258.72M |
| 99 | NRIX | Nurix Therapeutics, Inc. | 1.94B | -0.98% | 17,289 | 83.69M |
| 100 | GLUE | Monte Rosa Therapeutics, Inc. | 1.93B | 0.29% | 83,577 | 181.54M |
| 101 | MAZE | Maze Therapeutics, Inc. | 1.90B | -1.87% | 57 | 2.50M |
| 102 | SNDX | Syndax Pharmaceuticals, Inc. | 1.88B | 2.86% | 81,577 | 111.30M |
| 103 | ARDX | Ardelyx, Inc. | 1.81B | -3.88% | 397,020 | 398.23M |
| 104 | ERAS | Erasca, Inc. | 1.79B | -6.51% | 788,112 | - |
| 105 | MNKD | MannKind Corporation | 1.79B | -0.34% | 113,319 | 313.79M |
| 106 | CLDX | Celldex Therapeutics, Inc. | 1.78B | -2.19% | 5,009 | 2.60M |
| 107 | NBY | NovaBay Pharmaceuticals, Inc. | 1.78B | -26.41% | 992,382 | 10.30M |
| 108 | ZYME | Zymeworks Inc. | 1.71B | -1.51% | 70,310 | 134.48M |
| 109 | KOD | Kodiak Sciences Inc. | 1.70B | -0.79% | 20,220 | - |
| 110 | PHVS | Pharvaris N.V. | 1.69B | 0.58% | 130 | - |
| 111 | IMCR | Immunocore Holdings plc | 1.67B | 0.03% | 6,461 | 379.59M |
| 112 | SION | Sionna Therapeutics, Inc. | 1.66B | -5.11% | 4,472 | - |
| 113 | DNTH | Dianthus Therapeutics, Inc. | 1.62B | -0.84% | 9,343 | 3.08M |
| 114 | UPB | Upstream Bio, Inc. | 1.62B | 0.84% | 21,289 | 2.80M |
| 115 | AGIO | Agios Pharmaceuticals, Inc. | 1.62B | -2.29% | 25 | 44.79M |
| 116 | FTRE | Fortrea Holdings Inc. | 1.61B | 0.06% | 49,443 | 2.76B |
| 117 | PGEN | Precigen, Inc. | 1.58B | -2.61% | 257,348 | 6.31M |
| 118 | STOK | Stoke Therapeutics, Inc. | 1.56B | -16.65% | 289,913 | 205.63M |
| 119 | TYRA | Tyra Biosciences, Inc. | 1.54B | -1.42% | 12,112 | - |
| 120 | ELVN | Enliven Therapeutics, Inc. | 1.49B | -3.58% | 62,041 | - |
| 121 | QURE | uniQure N.V. | 1.48B | -6.28% | 271,949 | 15.75M |
| 122 | INVA | Innoviva, Inc. | 1.47B | 0.61% | 27,616 | 388.52M |
| 123 | BHVN | Biohaven Ltd. | 1.47B | -0.18% | 107,706 | - |
| 124 | TNGX | Tango Therapeutics, Inc. | 1.47B | -7.15% | 159,989 | 66.50M |
| 125 | MBX | MBX Biosciences, Inc. | 1.47B | 3.17% | 17,576 | - |
| 126 | TRVI | Trevi Therapeutics, Inc. | 1.43B | -0.58% | 44,787 | - |
| 127 | OCS | Oculis Holding AG | 1.40B | 5.24% | 36,855 | 992.00K |
| 128 | ATAI | AtaiBeckley Inc. | 1.38B | 1.33% | 319,694 | 3.02M |
| 129 | ABCL | AbCellera Biologics Inc. | 1.38B | 5.49% | 893,461 | 35.33M |
| 130 | SVRA | Savara Inc. | 1.37B | -2.07% | 32,611 | - |
| 131 | RLAY | Relay Therapeutics, Inc. | 1.37B | -0.88% | 83,913 | 8.36M |
| 132 | RAPP | Rapport Therapeutics, Inc. | 1.36B | -1.45% | 1,089 | - |
| 133 | MNMD | Mind Medicine (MindMed) Inc. | 1.36B | -0.36% | 102,246 | - |
| 134 | ORKA | Oruka Therapeutics, Inc. | 1.35B | -0.22% | 24,657 | - |
| 135 | EYPT | EyePoint, Inc. | 1.34B | -0.18% | 48,818 | 42.34M |
| 136 | MLTX | MoonLake Immunotherapeutics | 1.32B | -0.22% | 667,249 | - |
| 137 | TSHA | Taysha Gene Therapies, Inc. | 1.30B | -4.42% | 140,505 | 6.31M |
| 138 | XERS | Xeris Biopharma Holdings, Inc. | 1.30B | -1.51% | 55,612 | 266.14M |
| 139 | PHAR | Pharming Group N.V. | 1.28B | 0.43% | 9,332 | 362.27M |
| 140 | SPRY | ARS Pharmaceuticals, Inc. | 1.26B | -2.53% | 265,124 | 142.77M |
| 141 | NTLA | Intellia Therapeutics, Inc. | 1.25B | 3.95% | 611,135 | 57.53M |
| 142 | ANAB | AnaptysBio, Inc. | 1.25B | 0.69% | 19,582 | 169.47M |
| 143 | AKTS | Aktis Oncology, Inc. | 1.23B | 4.91% | 148,029 | 5.56M |
| 144 | IMTX | Immatics N.V. | 1.23B | 0.11% | 9,661 | 99.45M |
| 145 | CAPR | Capricor Therapeutics, Inc. | 1.22B | -1.01% | 63,371 | 11.13M |
| 146 | SANA | Sana Biotechnology, Inc. | 1.22B | 0.22% | 155,997 | - |
| 147 | NVAX | Novavax, Inc. | 1.18B | 0.14% | 198,467 | 1.06B |
| 148 | DAWN | Day One Biopharmaceuticals, Inc. | 1.12B | 22.48% | 1,248,261 | 133.67M |
| 149 | SEPN | Septerna, Inc. | 1.12B | -0.79% | 5,076 | 22.05M |
| 150 | PVLA | Palvella Therapeutics, Inc. | 1.08B | -1.03% | 2,371 | - |
| 151 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 1.04B | -1.52% | 14,330 | - |
| 152 | ZBIO | Zenas BioPharma, Inc. | 1.02B | 18.47% | 253,346 | 15.00M |
| 153 | PHAT | Phathom Pharmaceuticals, Inc. | 1.02B | -4.76% | 32,327 | 147.19M |
| 154 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.01B | 0.89% | 185,320 | 192.44M |
| 155 | INBX | Inhibrx Biosciences, Inc. | 1.01B | -4.41% | 23,721 | 1.40M |
| 156 | XNCR | Xencor, Inc. | 1.01B | 1.66% | 105,879 | 150.13M |
| 157 | NBTX | Nanobiotix S.A. | 999.43M | -1.27% | 648 | 11.93M |
| 158 | VTYX | Ventyx Biosciences, Inc. | 990.15M | -0.07% | 73,702 | - |
| 159 | IOVA | Iovance Biotherapeutics, Inc. | 976.54M | 0.41% | 1,152,127 | 250.43M |
| 160 | URGN | UroGen Pharma Ltd. | 975.03M | -1.98% | 96,423 | 96.52M |
| 161 | TBPH | Theravance Biopharma, Inc. | 960.75M | -0.42% | 10,215 | 80.33M |
| 162 | BCAX | Bicara Therapeutics Inc. | 955.40M | -2.84% | 14,082 | - |
| 163 | CMPX | Compass Therapeutics, Inc. | 940.89M | -1.12% | 69,522 | 850.00K |
| 164 | RAPT | RAPT Therapeutics, Inc. | 931.64M | - | 3 | - |
| 165 | GHRS | GH Research PLC | 930.44M | -0.07% | 7,833 | - |
| 166 | IVA | Inventiva S.A. | 909.94M | 7.25% | 18,326 | 19.93M |
| 167 | MDXG | MiMedx Group, Inc. | 907.87M | 0.49% | 38,573 | 393.44M |
| 168 | ORIC | ORIC Pharmaceuticals, Inc. | 876.99M | -1.58% | 55,093 | - |
| 169 | ABUS | Arbutus Biopharma Corporation | 875.07M | -1.52% | 19,384 | 14.61M |
| 170 | OMER | Omeros Corporation | 869.24M | -1.84% | 342,152 | - |
| 171 | YDES | YD Bio Limited | 867.75M | - | 1,119 | 510.36K |
| 172 | VALN | Valneva SE | 855.26M | 3.34% | 226 | 211.09M |
| 173 | JANX | Janux Therapeutics, Inc. | 843.27M | -0.99% | 33,084 | 10.00M |
| 174 | GERN | Geron Corporation | 842.63M | -1.49% | 824,816 | 183.40M |
| 175 | AVBP | ArriVent BioPharma, Inc. | 833.88M | -1.56% | 7,312 | - |
| 176 | VIR | Vir Biotechnology, Inc. | 825.01M | 1.37% | 116,614 | 16.86M |
| 177 | KALV | KalVista Pharmaceuticals, Inc. | 816.83M | -3.81% | 33,560 | 1.43M |
| 178 | KURA | Kura Oncology, Inc. | 811.00M | -0.96% | 74,777 | 104.03M |
| 179 | ANNX | Annexon, Inc. | 793.72M | 1.43% | 90,546 | - |
| 180 | MPLT | MapLight Therapeutics, Inc. | 786.42M | - | 29 | - |
| 181 | NKTR | Nektar Therapeutics | 783.56M | -3.00% | 56,597 | 62.60M |
| 182 | RGNX | REGENXBIO Inc. | 782.13M | 5.89% | 177,177 | 161.32M |
| 183 | ARVN | Arvinas, Inc. | 767.48M | -0.99% | 153,931 | 312.30M |
| 184 | PRME | Prime Medicine, Inc. | 757.72M | 8.63% | 497,741 | 5.98M |
| 185 | RIGL | Rigel Pharmaceuticals, Inc. | 727.78M | -1.82% | 61,440 | 282.08M |
| 186 | ATXS | Astria Therapeutics, Inc. | 724.41M | -1.48% | 27,464 | 706.00K |
| 187 | CTMX | CytomX Therapeutics, Inc. | 721.79M | -2.07% | 185,415 | 113.63M |
| 188 | DBVT | DBV Technologies S.A. | 705.91M | 3.26% | 26,254 | 5.50M |
| 189 | IVVD | Invivyd, Inc. | 692.81M | -0.79% | 143,556 | 50.04M |
| 190 | PROK | ProKidney Corp. | 688.91M | -2.14% | 30,019 | 744.00K |
| 191 | DRUG | Bright Minds Biosciences Inc. | 687.66M | - | 217 | - |
| 192 | FULC | Fulcrum Therapeutics, Inc. | 660.36M | 1.62% | 49,358 | 80.00M |
| 193 | GYRE | Gyre Therapeutics, Inc. | 651.68M | -3.11% | 745 | 107.27M |
| 194 | CGEM | Cullinan Therapeutics, Inc. | 643.93M | - | 13,714 | - |
| 195 | REPL | Replimune Group, Inc. | 635.39M | 0.87% | 113,592 | - |
| 196 | EVMN | Evommune, Inc. | 629.69M | -0.77% | 3,286 | 13.00M |
| 197 | JBIO | Jade Biosciences, Inc. | 618.76M | -0.59% | 6,746 | - |
| 198 | GOSS | Gossamer Bio, Inc. | 606.42M | 4.80% | 291,115 | 44.05M |
| 199 | LXEO | Lexeo Therapeutics, Inc. | 592.66M | -22.96% | 429,976 | - |
| 200 | ENGN | enGene Holdings Inc. | 590.13M | - | 236 | - |
| 201 | DRTS | Alpha Tau Medical Ltd. | 584.91M | -1.01% | 119,667 | - |
| 202 | VSTM | Verastem, Inc. | 579.64M | -3.59% | 130,554 | 13.38M |
| 203 | MGTX | MeiraGTx Holdings plc | 579.53M | -2.83% | 20,692 | 27.42M |
| 204 | KROS | Keros Therapeutics, Inc. | 568.50M | -2.81% | 28,640 | 246.72M |
| 205 | CRMD | CorMedix Inc. | 560.98M | -6.68% | 845,062 | 214.30M |
| 206 | TENX | Tenax Therapeutics, Inc. | 559.47M | 3.68% | 10,896 | - |
| 207 | VOR | Vor Biopharma Inc. | 552.15M | 5.47% | 187,253 | - |
| 208 | DNA | Ginkgo Bioworks Holdings, Inc. | 535.97M | 2.06% | 35,051 | 180.61M |
| 209 | DSGN | Design Therapeutics, Inc. | 524.07M | -2.02% | 134 | - |
| 210 | LBRX | LB Pharmaceuticals Inc | 522.68M | -0.34% | 7,029 | - |
| 211 | LYEL | Lyell Immunopharma, Inc. | 521.54M | - | 243 | 41.00K |
| 212 | NAGE | Niagen Bioscience, Inc. | 520.58M | -0.31% | 35,876 | 124.71M |
| 213 | SLS | SELLAS Life Sciences Group, Inc. | 518.49M | 5.20% | 2,123,680 | - |
| 214 | ANRO | Alto Neuroscience, Inc. | 508.56M | - | 10 | - |
| 215 | ASMB | Assembly Biosciences, Inc. | 502.04M | - | 61 | 37.19M |
| 216 | CRVS | Corvus Pharmaceuticals, Inc. | 500.37M | -1.33% | 44,380 | - |
| 217 | OCGN | Ocugen, Inc. | 499.71M | 6.67% | 967,524 | 5.37M |
| 218 | ABSI | Absci Corporation | 496.23M | -1.05% | 411,175 | 2.82M |
| 219 | PRTA | Prothena Corporation plc | 484.47M | -2.07% | 36,167 | 11.79M |
| 220 | ZVRA | Zevra Therapeutics, Inc. | 470.65M | -1.53% | 50,500 | 84.39M |
| 221 | KYTX | Kyverna Therapeutics, Inc. | 469.03M | -1.32% | 64,829 | - |
| 222 | LENZ | LENZ Therapeutics, Inc. | 458.40M | -1.48% | 1,661,295 | 17.50M |
| 223 | AUTL | Autolus Therapeutics plc | 457.77M | -4.97% | 541,199 | 51.13M |
| 224 | BCYC | Bicycle Therapeutics plc | 455.75M | -1.05% | 18,151 | 28.34M |
| 225 | ADCT | ADC Therapeutics SA | 455.25M | 0.41% | 28,811 | 75.21M |
| 226 | ALT | Altimmune, Inc. | 448.63M | 2.24% | 368,357 | 20.00K |
| 227 | VTVT | vTv Therapeutics Inc. | 446.97M | 1.25% | 497 | 17.00K |
| 228 | FBRX | Forte Biosciences, Inc. | 440.97M | 3.56% | 11,557 | - |
| 229 | NBP | NovaBridge Biosciences | 438.11M | 2.70% | 82,592 | - |
| 230 | IMMP | Immutep Limited | 428.12M | 0.51% | 2,320 | 3.31M |
| 231 | DMAC | DiaMedica Therapeutics Inc. | 428.09M | -2.08% | 134,643 | - |
| 232 | PEPG | PepGen Inc. | 427.61M | -3.86% | 36,561 | - |
| 233 | FDMT | 4D Molecular Therapeutics, Inc. | 426.23M | -0.53% | 72,457 | 120.00K |
| 234 | VNDA | Vanda Pharmaceuticals Inc. | 425.50M | -1.77% | 62,849 | 212.07M |
| 235 | PRTC | PureTech Health plc | 418.60M | - | - | 6.39M |
| 236 | LXRX | Lexicon Pharmaceuticals, Inc. | 416.09M | -2.14% | 169,964 | 70.86M |
| 237 | LCTX | Lineage Cell Therapeutics, Inc. | 410.75M | -0.88% | 134,297 | 10.82M |
| 238 | EPRX | Eupraxia Pharmaceuticals Inc. | 410.41M | -3.08% | 1,561 | - |
| 239 | MNPR | Monopar Therapeutics Inc. | 407.64M | -3.17% | 27,913 | - |
| 240 | BNTC | Benitec Biopharma Inc. | 405.33M | 1.10% | 49,168 | - |
| 241 | ALLO | Allogene Therapeutics, Inc. | 402.27M | 4.68% | 991,460 | 22.00K |
| 242 | SLDB | Solid Biosciences Inc. | 399.29M | -3.12% | 54,452 | - |
| 243 | RCKT | Rocket Pharmaceuticals, Inc. | 387.44M | -4.02% | 182,414 | - |
| 244 | AVXL | Anavex Life Sciences Corp. | 380.62M | -0.47% | 67,657 | - |
| 245 | TECX | Tectonic Therapeutic, Inc. | 371.52M | -3.45% | 49 | - |
| 246 | HELP | Cybin Inc. | 370.78M | -1.33% | 37,681 | - |
| 247 | NMRA | Neumora Therapeutics, Inc. | 367.07M | -2.70% | 177,292 | - |
| 248 | ENTA | Enanta Pharmaceuticals, Inc. | 364.53M | -3.66% | 19,843 | 65.32M |
| 249 | TRDA | Entrada Therapeutics, Inc. | 359.33M | - | 40 | 61.52M |
| 250 | XFOR | X4 Pharmaceuticals, Inc. | 340.57M | -2.62% | 11,298 | 33.98M |
| 251 | CTNM | Contineum Therapeutics, Inc. | 339.72M | -0.11% | - | - |
| 252 | XOMA | XOMA Royalty Corporation | 336.70M | -8.91% | 130,423 | 47.11M |
| 253 | ACIU | AC Immune SA | 335.42M | -0.59% | 31,910 | 5.48M |
| 254 | ZURA | Zura Bio Limited | 332.92M | - | 33,948 | - |
| 255 | GLSI | Greenwich LifeSciences, Inc. | 332.51M | -5.06% | 24,240 | - |
| 256 | CLLS | Cellectis S.A. | 324.74M | - | 105 | 82.55M |
| 257 | RLMD | Relmada Therapeutics, Inc. | 319.00M | 0.93% | 21,435 | - |
| 258 | AURA | Aura Biosciences, Inc. | 317.52M | -1.77% | 6,636 | - |
| 259 | FHTX | Foghorn Therapeutics Inc. | 314.43M | 7.75% | 33,928 | 24.52M |
| 260 | AARD | Aardvark Therapeutics, Inc. | 313.43M | 0.88% | 3,265 | - |
| 261 | CADL | Candel Therapeutics, Inc. | 311.27M | -0.70% | 28,276 | - |
| 262 | CAMP | Camp4 Therapeutics Corporation | 307.66M | - | 25 | 3.80M |
| 263 | AVTX | Avalo Therapeutics, Inc. | 307.46M | 0.03% | 6,212 | 192.00K |
| 264 | PBYI | Puma Biotechnology, Inc. | 304.87M | -0.98% | 9,727 | 212.00M |
| 265 | TARA | Protara Therapeutics, Inc. | 297.95M | -3.30% | 40,992 | - |
| 266 | IMRX | Immuneering Corporation | 293.79M | -2.26% | 341,350 | - |
| 267 | ACHV | Achieve Life Sciences, Inc. | 290.13M | -1.98% | 48,317 | - |
| 268 | MENS | Jyong Biotech Ltd. | 289.91M | -1.05% | 16,422 | - |
| 269 | STTK | Shattuck Labs, Inc. | 286.34M | -4.74% | 66,618 | 1.00M |
| 270 | PALI | Palisade Bio, Inc. | 280.13M | -5.53% | 1,979,087 | - |
| 271 | ACRS | Aclaris Therapeutics, Inc. | 278.45M | -2.65% | 47,433 | 15.74M |
| 272 | NGNE | Neurogene Inc. | 277.58M | - | 265 | 925.00K |
| 273 | LRMR | Larimar Therapeutics, Inc. | 277.31M | -2.70% | 172,891 | - |
| 274 | ABEO | Abeona Therapeutics Inc. | 276.38M | -1.73% | 55,147 | 400.00K |
| 275 | OABI | OmniAb, Inc. | 274.95M | - | 6,347 | 21.09M |
| 276 | HRTX | Heron Therapeutics, Inc. | 273.21M | 7.19% | 120,339 | 155.10M |
| 277 | GUTS | Fractyl Health, Inc. | 269.98M | -1.50% | 186,399 | 3.00K |
| 278 | AVIR | Atea Pharmaceuticals, Inc. | 269.54M | - | 800 | - |
| 279 | FENC | Fennec Pharmaceuticals Inc. | 263.66M | -0.64% | 6,851 | 38.79M |
| 280 | OBIO | Orchestra BioMed Holdings, Inc. | 261.43M | -3.54% | 34,647 | 2.82M |
| 281 | SLN | Silence Therapeutics plc | 259.79M | -0.36% | 64,168 | 25.83M |
| 282 | ARMP | Armata Pharmaceuticals, Inc. | 256.67M | - | 2,089 | 5.05M |
| 283 | NAUT | Nautilus Biotechnology, Inc. | 255.14M | -1.94% | 970 | - |
| 284 | IMMX | Immix Biopharma, Inc. | 251.88M | -1.85% | 117,579 | - |
| 285 | CLYM | Climb Bio, Inc. | 243.50M | 1.39% | 61,377 | - |
| 286 | RZLT | Rezolute, Inc. | 242.02M | -0.76% | 135,247 | - |
| 287 | ALDX | Aldeyra Therapeutics, Inc. | 241.55M | -2.31% | 61,156 | - |
| 288 | MDWD | MediWound Ltd. | 237.20M | -1.07% | 12,020 | 20.93M |
| 289 | ZNTL | Zentalis Pharmaceuticals, Inc. | 225.98M | -6.68% | 1,941,948 | 26.87M |
| 290 | IKT | Inhibikase Therapeutics, Inc. | 225.69M | -3.79% | 3,692 | 1.00 |
| 291 | HUMA | Humacyte, Inc. | 223.88M | -0.85% | 439,134 | 1.57M |
| 292 | ENLV | Enlivex Therapeutics Ltd. | 221.57M | 3.52% | 119,461 | - |
| 293 | VYGR | Voyager Therapeutics, Inc. | 216.84M | -2.99% | 19,563 | 31.32M |
| 294 | NVCT | Nuvectis Pharma, Inc. | 215.42M | -0.59% | 3,144 | - |
| 295 | CBIO | Crescent Biopharma, Inc. | 215.05M | 1.95% | 9,160 | - |
| 296 | OVID | Ovid Therapeutics Inc. | 213.50M | -1.80% | 84,697 | 6.61M |
| 297 | RNAC | Cartesian Therapeutics, Inc. | 213.23M | - | 348 | 1.09M |
| 298 | ARCT | Arcturus Therapeutics Holdings Inc. | 209.98M | 9.00% | 163,839 | 97.60M |
| 299 | CABA | Cabaletta Bio, Inc. | 208.90M | 3.33% | 346,623 | - |
| 300 | PRLD | Prelude Therapeutics Incorporated | 208.88M | -3.61% | 29,484 | 10.50M |
| 301 | EDIT | Editas Medicine, Inc. | 205.00M | 1.45% | 162,175 | 46.38M |
| 302 | GALT | Galectin Therapeutics Inc. | 203.09M | - | 22,565 | - |
| 303 | CHRS | Coherus Oncology, Inc. | 201.85M | -1.18% | 158,259 | 277.73M |
| 304 | CCCC | C4 Therapeutics, Inc. | 201.10M | -3.04% | 118,650 | 30.11M |
| 305 | CRDF | Cardiff Oncology, Inc. | 200.06M | -3.57% | 73,876 | 501.00K |
| 306 | MIST | Milestone Pharmaceuticals Inc. | 199.61M | -3.68% | 740,151 | - |
| 307 | SGMT | Sagimet Biosciences Inc. | 195.78M | -3.06% | 124,957 | - |
| 308 | ALEC | Alector, Inc. | 195.38M | -3.76% | 62,152 | 69.05M |
| 309 | NTHI | NeOnc Technologies Holdings, Inc. | 194.74M | - | 2 | 59.99K |
| 310 | NERV | Minerva Neurosciences, Inc. | 188.24M | -2.25% | 4,407 | - |
| 311 | TNXP | Tonix Pharmaceuticals Holding Corp. | 187.73M | -2.13% | 51,822 | 10.30M |
| 312 | PRQR | ProQR Therapeutics N.V. | 176.98M | -5.08% | 144,035 | 18.86M |
| 313 | KLRS | Kalaris Therapeutics, Inc. | 176.55M | -3.48% | 5,121 | - |
| 314 | SABS | SAB Biotherapeutics, Inc. | 173.29M | -1.09% | 2,996 | 114.70K |
| 315 | CGEN | Compugen Ltd. | 172.11M | -2.13% | 40,510 | 6.90M |
| 316 | IPSC | Century Therapeutics, Inc. | 169.39M | - | 125,830 | 113.34M |
| 317 | PLX | Protalix BioTherapeutics, Inc. | 168.08M | 0.97% | 58,671 | 61.84M |
| 318 | RANI | Rani Therapeutics Holdings, Inc. | 167.70M | -1.43% | 130,849 | 1.20M |
| 319 | IPHA | Innate Pharma S.A. | 163.41M | 2.67% | 31 | 14.84M |
| 320 | SLGL | Sol-Gel Technologies Ltd. | 163.11M | 0.95% | 30 | 18.97M |
| 321 | TLSA | Tiziana Life Sciences Ltd | 162.79M | -4.20% | 51,132 | - |
| 322 | TNYA | Tenaya Therapeutics, Inc. | 161.69M | -2.33% | 594,313 | - |
| 323 | VXRT | Vaxart, Inc. | 159.59M | -2.21% | - | 148.20M |
| 324 | SRZN | Surrozen, Inc. | 158.49M | - | 5 | 3.60M |
| 325 | MOLN | Molecular Partners AG | 153.73M | - | 9 | 856.30K |
| 326 | KPTI | Karyopharm Therapeutics Inc. | 152.16M | -4.26% | 22,389 | 142.53M |
| 327 | CRBU | Caribou Biosciences, Inc. | 151.89M | -2.11% | 61,059 | 9.30M |
| 328 | CDXS | Codexis, Inc. | 149.94M | 1.22% | 11,774 | 52.93M |
| 329 | QNCX | Quince Therapeutics, Inc. | 149.78M | - | 122 | - |
| 330 | SGMO | Sangamo Therapeutics, Inc. | 149.74M | 0.45% | 246,734 | 32.88M |
| 331 | BDTX | Black Diamond Therapeutics, Inc. | 149.27M | -6.76% | 224,820 | 70.00M |
| 332 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 148.23M | -3.73% | 12,809 | - |
| 333 | ACOG | Alpha Cognition Inc. | 147.63M | 3.98% | 292 | 7.43M |
| 334 | NKTX | Nkarta, Inc. | 146.32M | -1.44% | 29,146 | - |
| 335 | CNTX | Context Therapeutics Inc. | 146.09M | -1.24% | 50,923 | - |
| 336 | SPRO | Spero Therapeutics, Inc. | 141.98M | -1.18% | 11,797 | 40.55M |
| 337 | MCRB | Seres Therapeutics, Inc. | 141.58M | - | 1,067 | 351.00K |
| 338 | ELDN | Eledon Pharmaceuticals, Inc. | 140.45M | 2.31% | 211,830 | - |
| 339 | ELTX | Elicio Therapeutics, Inc. | 139.98M | -0.62% | 4,040 | - |
| 340 | ACTU | Actuate Therapeutics, Inc. | 137.60M | -3.58% | 32,158 | - |
| 341 | AGEN | Agenus Inc. | 136.37M | 2.56% | 103,884 | 106.83M |
| 342 | TTRX | Turn Therapeutics Inc. | 135.45M | -0.43% | 934 | - |
| 343 | HYFT | MindWalk Holdings Corp. | 135.40M | 6.62% | 652,877 | 19.02M |
| 344 | ORMP | Oramed Pharmaceuticals Inc. | 134.93M | -1.17% | 2,282 | 2.00M |
| 345 | IRD | Opus Genetics, Inc. | 131.72M | -1.04% | 41,227 | 14.63M |
| 346 | UNCY | Unicycive Therapeutics, Inc. | 129.16M | -2.75% | 169,352 | - |
| 347 | FBIO | Fortress Biotech, Inc. | 128.81M | -3.49% | 409,650 | 62.30M |
| 348 | VRCA | Verrica Pharmaceuticals Inc. | 128.40M | 1.07% | 6,936 | 30.83M |
| 349 | CGTX | Cognition Therapeutics, Inc. | 128.00M | 2.84% | 167,251 | - |
| 350 | WHWK | Whitehawk Therapeutics, Inc. | 124.42M | - | 55 | 14.38M |
| 351 | FATE | Fate Therapeutics, Inc. | 122.85M | 1.43% | 226,518 | 7.14M |
| 352 | PYXS | Pyxis Oncology, Inc. | 122.66M | 11.93% | 1,304,090 | 2.82M |
| 353 | ARTV | Artiva Biotherapeutics, Inc. | 120.27M | 0.93% | 70,610 | 251.00K |
| 354 | CNTB | Connect Biopharma Holdings Limited | 120.19M | - | 453 | 762.00K |
| 355 | MGNX | MacroGenics, Inc. | 113.23M | -2.19% | 55,042 | 127.63M |
| 356 | RPTX | Repare Therapeutics Inc. | 109.93M | 0.39% | 33,382 | 11.87M |
| 357 | SEER | Seer, Inc. | 109.69M | - | 41,575 | 16.38M |
| 358 | ANIX | Anixa Biosciences, Inc. | 108.95M | -2.07% | 27,080 | - |
| 359 | BMEA | Biomea Fusion, Inc. | 108.88M | 8.45% | 378,067 | - |
| 360 | OKYO | OKYO Pharma Limited | 105.31M | 1.45% | 43,689 | - |
| 361 | INO | Inovio Pharmaceuticals, Inc. | 105.12M | -1.92% | 205,767 | 182.34K |
| 362 | ABOS | Acumen Pharmaceuticals, Inc. | 104.79M | -4.42% | 24,209 | - |
| 363 | STRO | Sutro Biopharma, Inc. | 104.19M | - | 165 | 105.65M |
| 364 | THAR | Tharimmune, Inc. | 103.87M | 2.15% | 74,679 | - |
| 365 | ONCY | Oncolytics Biotech Inc. | 103.84M | -0.28% | 141,622 | - |
| 366 | CBUS | Cibus, Inc. | 101.94M | - | 3 | 3.79M |
| 367 | GNLX | Genelux Corporation | 101.57M | -3.57% | 42,791 | 8.00K |
| 368 | SAVA | Cassava Sciences, Inc. | 100.96M | -0.48% | 112,207 | - |
| 369 | COYA | Coya Therapeutics, Inc. | 97.72M | -3.71% | 45,392 | 3.99M |
| 370 | VANI | Vivani Medical, Inc. | 97.03M | - | 1,307 | - |
| 371 | CSBR | Champions Oncology, Inc. | 94.15M | - | 34 | 58.42M |
| 372 | ANVS | Annovis Bio, Inc. | 93.03M | -4.36% | 55,353 | - |
| 373 | DTIL | Precision BioSciences, Inc. | 92.80M | -1.66% | 31,095 | 698.00K |
| 374 | MREO | Mereo BioPharma Group plc | 92.09M | 17.05% | 9,745,797 | 500.00K |
| 375 | ETHZ | ETHZilla Corporation | 91.26M | 0.42% | 31,109 | 4.11M |
| 376 | KRRO | Korro Bio, Inc. | 87.39M | -2.32% | 9,454 | 7.37M |
| 377 | GANX | Gain Therapeutics, Inc. | 85.39M | -3.90% | 106,293 | - |
| 378 | DWTX | Dogwood Therapeutics, Inc. | 85.32M | 0.70% | 7,798 | - |
| 379 | CALC | CalciMedica, Inc. | 84.30M | - | 52 | - |
| 380 | SPRB | Spruce Biosciences, Inc. | 83.69M | -2.25% | - | 697.00K |
| 381 | COEP | Coeptis Therapeutics Holdings, Inc. | 82.82M | 1.96% | 441 | 501.00K |
| 382 | IMUX | Immunic, Inc. | 81.23M | 1.56% | 274,939 | - |
| 383 | EXOZ | eXoZymes, Inc. | 80.94M | - | 3 | -700.00 |
| 384 | ACET | Adicet Bio, Inc. | 80.35M | -1.00% | 18,807 | - |
| 385 | PTHS | Pelthos Therapeutics Inc. | 80.02M | - | 36 | 7.41M |
| 386 | ATOS | Atossa Therapeutics, Inc. | 80.02M | -3.97% | 37,769 | - |
| 387 | PLRX | Pliant Therapeutics, Inc. | 79.88M | -1.52% | 74,267 | - |
| 388 | XBIT | XBiotech Inc. | 78.35M | 0.39% | - | - |
| 389 | TVGN | Tevogen Bio Holdings Inc. | 78.30M | 1.31% | 109,605 | - |
| 390 | ADAG | Adagene Inc. | 77.77M | 7.84% | 10,097 | 103.20K |
| 391 | PYPD | PolyPid Ltd. | 76.52M | -0.86% | 18,218 | - |
| 392 | ALXO | ALX Oncology Holdings Inc. | 75.91M | 3.70% | 1,588 | - |
| 393 | KZIA | Kazia Therapeutics Limited | 75.29M | 1.32% | 15,649 | 1.20M |
| 394 | ENTX | Entera Bio Ltd. | 73.37M | - | - | 124.00K |
| 395 | IMA | ImageneBio, Inc. | 73.07M | -1.15% | 135 | 800.00K |
| 396 | EQ | Equillium, Inc. | 72.77M | 4.82% | 221,886 | 4.39M |
| 397 | IFRX | InflaRx N.V. | 72.49M | 2.88% | 30,483 | 73.73K |
| 398 | CRVO | CervoMed Inc. | 71.57M | - | 33 | 6.16M |
| 399 | ATYR | aTyr Pharma, Inc. | 70.14M | 0.43% | 157,420 | 190.00K |
| 400 | PSTV | Plus Therapeutics, Inc. | 69.00M | -9.56% | 1,528,555 | 5.26M |
| 401 | MNOV | MediciNova, Inc. | 68.92M | -7.74% | 809 | 257.92K |
| 402 | TCRX | TScan Therapeutics, Inc. | 68.38M | -0.41% | 26,689 | 8.42M |
| 403 | MGX | Metagenomi, Inc. | 66.83M | -0.56% | 16,473 | 30.91M |
| 404 | BYSI | BeyondSpring Inc. | 64.15M | -1.89% | 945 | 1.88M |
| 405 | NRXP | NRx Pharmaceuticals, Inc. | 63.36M | -3.60% | 128,817 | 242.00K |
| 406 | PMVP | PMV Pharmaceuticals, Inc. | 62.79M | - | 21,626 | - |
| 407 | PASG | Passage Bio, Inc. | 62.65M | -0.71% | 177 | - |
| 408 | MAIA | MAIA Biotechnology, Inc. | 61.23M | -1.84% | 36,087 | - |
| 409 | PDSB | PDS Biotechnology Corporation | 58.83M | 0.47% | 260,097 | - |
| 410 | ICCC | ImmuCell Corporation | 58.75M | - | 3 | 27.77M |
| 411 | IBIO | iBio, Inc. | 58.47M | -3.70% | 288,648 | 500.00K |
| 412 | INKT | MiNK Therapeutics, Inc. | 58.21M | - | 11,782 | - |
| 413 | ATHE | Alterity Therapeutics Limited | 58.10M | - | 50 | 3.57M |
| 414 | ANL | Adlai Nortye Ltd. | 57.20M | -3.13% | 32,190 | -1.35M |
| 415 | RADX | Radiopharm Theranostics Limited | 56.81M | 0.58% | 3,631 | 8.20M |
| 416 | GRCE | Grace Therapeutics, Inc. | 56.48M | -1.08% | 9,262 | - |
| 417 | ALGS | Aligos Therapeutics, Inc. | 55.44M | 0.11% | 3,394 | 2.65M |
| 418 | ACRV | Acrivon Therapeutics, Inc. | 53.96M | -2.29% | 514,063 | - |
| 419 | NTRB | Nutriband Inc. | 53.12M | - | 12 | 2.28M |
| 420 | LITS | Lite Strategy, Inc. | 52.76M | -2.38% | 14,265 | - |
| 421 | IBO | Impact BioMedical Inc. | 52.75M | -0.16% | 5,612 | 25.00K |
| 422 | OSTX | OS Therapies Incorporated | 52.47M | -3.87% | 198,042 | - |
| 423 | ABVC | ABVC BioPharma, Inc. | 51.85M | 0.92% | 5,991 | 797.92K |
| 424 | NRXS | NeurAxis, Inc. | 51.59M | -0.35% | 277 | 3.36M |
| 425 | HURA | TuHURA Biosciences, Inc. | 47.36M | 3.49% | 4,962 | - |
| 426 | PTN | Palatin Technologies, Inc. | 47.18M | - | 31 | 8.85M |
| 427 | TIL | Instil Bio, Inc. | 46.93M | -2.95% | 7,657 | - |
| 428 | NXTC | NextCure, Inc. | 46.87M | - | 5 | - |
| 429 | CVM | CEL-SCI Corporation | 46.67M | 1.28% | 11,015 | - |
| 430 | ANEB | Anebulo Pharmaceuticals, Inc. | 46.43M | -0.88% | 2,295 | - |
| 431 | TELO | Telomir Pharmaceuticals, Inc. | 46.07M | -1.47% | 22,991 | - |
| 432 | KZR | Kezar Life Sciences, Inc. | 45.40M | - | - | - |
| 433 | ATRA | Atara Biotherapeutics, Inc. | 45.14M | -54.21% | 1,592,966 | 151.93M |
| 434 | QTTB | Q32 Bio Inc. | 45.03M | 1.67% | 9,598 | - |
| 435 | ESLA | Estrella Immunopharma, Inc. | 44.98M | -10.83% | 17,161 | - |
| 436 | APLM | Apollomics, Inc. | 44.66M | -5.28% | 2 | 6.93M |
| 437 | LPCN | Lipocine Inc. | 44.62M | 0.34% | 516 | 4.32M |
| 438 | ATNM | Actinium Pharmaceuticals, Inc. | 43.05M | -0.72% | 7,981 | 90.00K |
| 439 | OKUR | OnKure Therapeutics, Inc. | 42.54M | - | 6,525 | - |
| 440 | JSPR | Jasper Therapeutics, Inc. | 42.40M | 0.33% | 88,957 | - |
| 441 | EVAX | Evaxion A/S | 42.37M | - | 3,866 | 7.65M |
| 442 | IOBT | IO Biotech, Inc. | 41.88M | 3.50% | 30,534 | - |
| 443 | TVRD | Tvardi Therapeutics, Inc. | 41.56M | -2.64% | 11,219 | - |
| 444 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 41.10M | 3.44% | 584,579 | - |
| 445 | LTRN | Lantern Pharma Inc. | 39.93M | 2.29% | 823 | - |
| 446 | INMB | INmune Bio, Inc. | 39.88M | 0.67% | 20,118 | 50.00K |
| 447 | RNXT | RenovoRx, Inc. | 38.48M | -6.25% | 377,391 | 928.00K |
| 448 | VERU | Veru Inc. | 38.12M | -0.63% | 5,785 | 16.89M |
| 449 | GBIO | Generation Bio Co. | 36.93M | - | 2,370 | 15.27M |
| 450 | XCUR | Exicure, Inc. | 36.84M | -1.03% | 7,245 | 500.00K |
| 451 | OTLK | Outlook Therapeutics, Inc. | 36.55M | -3.39% | 1,095,780 | 1.41M |
| 452 | JUNS | Jupiter Neurosciences, Inc. | 36.49M | - | 205 | - |
| 453 | XLO | Xilio Therapeutics, Inc. | 35.97M | 0.75% | 5,310 | 31.80M |
| 454 | ANTX | AN2 Therapeutics, Inc. | 35.62M | - | 23,238 | - |
| 455 | CELU | Celularity Inc. | 35.60M | -3.85% | 325 | 40.58M |
| 456 | DYAI | Dyadic International, Inc. | 34.38M | 0.01% | 200 | 3.34M |
| 457 | GLTO | Galecto, Inc. | 34.06M | 4.15% | 6,018 | - |
| 458 | CING | Cingulate Inc. | 33.26M | - | 73 | - |
| 459 | GNTA | Genenta Science S.p.A. | 32.81M | -1.41% | 12,620 | - |
| 460 | LIXT | Lixte Biotechnology Holdings, Inc. | 31.80M | - | 10 | - |
| 461 | SKYE | Skye Bioscience, Inc. | 31.42M | - | 33,368 | - |
| 462 | NRSN | NeuroSense Therapeutics Ltd. | 31.18M | -1.87% | - | - |
| 463 | CUE | Cue Biopharma, Inc. | 31.04M | -5.63% | 59,351 | 7.10M |
| 464 | BRNS | Barinthus Biotherapeutics plc | 31.01M | - | 11 | 14.97M |
| 465 | MRKR | Marker Therapeutics, Inc. | 30.85M | -7.50% | 109,916 | 4.69M |
| 466 | RNTX | Rein Therapeutics Inc. | 30.49M | -0.85% | 50,666 | - |
| 467 | RLYB | Rallybio Corporation | 29.79M | -0.70% | 29,638 | 674.00K |
| 468 | IGC | IGC Pharma, Inc. | 29.29M | 1.80% | 29,290 | 1.11M |
| 469 | HOWL | Werewolf Therapeutics, Inc. | 29.12M | -0.58% | 63,478 | 1.14M |
| 470 | SNTI | Senti Biosciences, Inc. | 28.92M | -0.90% | 47,085 | - |
| 471 | BOLD | Boundless Bio, Inc. | 28.88M | -1.53% | 389 | - |
| 472 | PLUR | Pluri Inc. | 28.14M | - | - | 1.33M |
| 473 | HYPD | Hyperion DeFi, Inc. | 27.96M | - | 1,712 | 345.32K |
| 474 | ATHA | Athira Pharma, Inc. | 27.29M | 2.52% | - | - |
| 475 | QNTM | Quantum BioPharma Ltd. | 27.04M | 3.75% | 789 | - |
| 476 | DARE | Daré Bioscience, Inc. | 27.01M | -4.55% | 20,285 | -57.13K |
| 477 | VTGN | Vistagen Therapeutics, Inc. | 26.07M | 0.02% | 127,769 | 721.00K |
| 478 | SER | Serina Therapeutics, Inc. | 25.70M | -5.12% | 13,926 | 116.00K |
| 479 | KLTO | Klotho Neurosciences, Inc. | 24.52M | - | 46,332 | - |
| 480 | INTS | Intensity Therapeutics, Inc. | 24.48M | -1.93% | 123,413 | - |
| 481 | NNVC | NanoViricides, Inc. | 24.37M | 0.89% | 21,906 | - |
| 482 | PLRZ | Polyrizon Ltd. | 24.30M | -3.75% | 2,124 | - |
| 483 | CASI | CASI Pharmaceuticals, Inc. | 23.84M | 5.45% | 5,033 | 26.85M |
| 484 | FBLG | FibroBiologics, Inc. | 22.62M | 0.59% | 39,469 | - |
| 485 | LNAI | Lunai Bioworks Inc. | 22.26M | -1.04% | 4,190 | - |
| 486 | NEUP | Neuphoria Therapeutics Inc. | 22.14M | -1.71% | 3,385 | 15.65M |
| 487 | KTTA | Pasithea Therapeutics Corp. | 21.71M | 0.93% | 15,030 | - |
| 488 | LIMN | Liminatus Pharma, Inc. | 20.84M | 6.05% | 35,230 | - |
| 489 | ALLR | Allarity Therapeutics, Inc. | 20.66M | 1.71% | 42,013 | - |
| 490 | BCAB | BioAtla, Inc. | 20.16M | -5.19% | 420,439 | 11.00M |
| 491 | VYNE | VYNE Therapeutics Inc. | 19.30M | 1.79% | - | 524.00K |
| 492 | CVKD | Cadrenal Therapeutics, Inc. | 19.08M | -0.12% | 9,688 | - |
| 493 | KAPA | Kairos Pharma, Ltd. | 18.83M | 2.76% | 6,847 | - |
| 494 | CLGN | CollPlant Biotechnologies Ltd. | 18.78M | - | 4 | 2.48M |
| 495 | MTVA | MetaVia Inc. | 17.95M | - | 83 | - |
| 496 | CTXR | Citius Pharmaceuticals, Inc. | 17.83M | -3.28% | 7,640 | - |
| 497 | LSTA | Lisata Therapeutics, Inc. | 17.82M | 2.54% | 464 | 1.07M |
| 498 | KALA | KALA BIO, Inc. | 17.53M | -1.74% | 53,079 | - |
| 499 | PMN | ProMIS Neurosciences, Inc. | 17.26M | -1.35% | 1,791 | - |
| 500 | ITRM | Iterum Therapeutics plc | 17.04M | -1.59% | 506,173 | 390.00K |
| 501 | OSRH | OSR Holdings, Inc. | 17.04M | 0.24% | 28,254,002 | -90.52K |
| 502 | LEXX | Lexaria Bioscience Corp. | 16.29M | -12.24% | 78,661 | 705.92K |
| 503 | HOTH | Hoth Therapeutics, Inc. | 16.29M | -2.78% | 24,368 | - |
| 504 | COCP | Cocrystal Pharma, Inc. | 15.58M | -0.88% | 10,091 | - |
| 505 | APLT | Applied Therapeutics, Inc. | 15.28M | -0.40% | 731,154 | 1.00M |
| 506 | GDTC | CytoMed Therapeutics Limited | 14.77M | -3.03% | 3,291 | 573.19K |
| 507 | BCDA | BioCardia, Inc. | 14.75M | -1.07% | 14,082 | 3.00K |
| 508 | CLRB | Cellectar Biosciences, Inc. | 14.59M | 11.69% | 335,403 | - |
| 509 | NCNA | NuCana plc | 14.36M | 2.37% | 4,611 | - |
| 510 | SNSE | Sensei Biotherapeutics, Inc. | 14.30M | -2.37% | 3,087 | - |
| 511 | GRDX | GridAI Technologies Corp. | 14.15M | -9.85% | 12,280 | - |
| 512 | TPST | Tempest Therapeutics, Inc. | 13.99M | -1.73% | 260 | - |
| 513 | BCTX | BriaCell Therapeutics Corp. | 13.58M | -2.90% | 4,458 | - |
| 514 | SNGX | Soligenix, Inc. | 13.57M | -0.37% | 15,561 | 2.34K |
| 515 | LGVN | Longeveron Inc. | 13.36M | 0.45% | 5,744 | 1.44M |
| 516 | SYBX | Synlogic, Inc. | 13.34M | - | 10 | 8.00K |
| 517 | BLRX | BioLineRx Ltd. | 13.25M | 1.54% | - | 12.74M |
| 518 | AKTX | Akari Therapeutics, Plc | 12.82M | -0.60% | 57,416 | - |
| 519 | AEON | AEON Biopharma, Inc. | 12.79M | - | 87,228 | - |
| 520 | IMNN | Imunon, Inc. | 12.58M | 0.27% | 778 | - |
| 521 | EDSA | Edesa Biotech, Inc. | 12.50M | - | 783 | - |
| 522 | PHIO | Phio Pharmaceuticals Corp. | 12.49M | - | 19,339 | - |
| 523 | MBRX | Moleculin Biotech, Inc. | 12.07M | -1.51% | 33,960 | - |
| 524 | TRAW | Traws Pharma, Inc. | 11.11M | 3.73% | 1,371 | 2.85M |
| 525 | CMMB | Chemomab Therapeutics Ltd. | 11.02M | - | 1,430 | - |
| 526 | ABP | Abpro Holdings, Inc. | 10.97M | - | 4 | 183.00K |
| 527 | BOLT | Bolt Biotherapeutics, Inc. | 10.79M | -3.60% | 120 | 5.20M |
| 528 | CRIS | Curis, Inc. | 10.73M | 0.39% | 79,180 | 11.65M |
| 529 | NCEL | NewcelX Ltd. | 10.62M | 6.39% | 1,613,947 | - |
| 530 | INAB | IN8bio, Inc. | 10.43M | -4.26% | 28,665 | - |
| 531 | BRTX | BioRestorative Therapies, Inc. | 10.39M | -2.09% | 1,000 | 383.40K |
| 532 | ASBP | Aspire Biopharma Holdings, Inc. | 10.20M | -8.75% | 4,089,247 | 1.94K |
| 533 | ERNA | Ernexa Therapeutics Inc. | 9.97M | -3.05% | 1,801 | 1,000.00 |
| 534 | EVGN | Evogene Ltd. | 9.90M | 1.22% | 4,777 | 8.02M |
| 535 | BIVI | BioVie Inc. | 9.87M | 3.15% | 1,615 | - |
| 536 | QNRX | Quoin Pharmaceuticals, Ltd. | 9.82M | -4.10% | 823 | - |
| 537 | PMCB | PharmaCyte Biotech, Inc. | 8.96M | 0.31% | 16,431 | - |
| 538 | PULM | Pulmatrix, Inc. | 8.76M | 1.59% | 564 | 3.00K |
| 539 | ALZN | Alzamend Neuro, Inc. | 8.74M | -3.77% | 15,705 | - |
| 540 | APM | Aptorum Group Limited | 8.71M | 1.90% | 757 | - |
| 541 | CLDI | Calidi Biotherapeutics, Inc. | 8.42M | - | 2,036 | - |
| 542 | MBIO | Mustang Bio, Inc. | 8.39M | -0.86% | 2,127 | - |
| 543 | APVO | Aptevo Therapeutics Inc. | 8.35M | -7.66% | 30,872 | - |
| 544 | CELZ | Creative Medical Technology Holdings, Inc. | 8.18M | 4.00% | 2,182 | 6.00K |
| 545 | ICU | SeaStar Medical Holding Corporation | 8.15M | - | 4,089 | 881.00K |
| 546 | ADXN | Addex Therapeutics Ltd | 8.06M | - | 1,260 | 198.82K |
| 547 | KPRX | Kiora Pharmaceuticals, Inc. | 7.89M | - | 112 | 20.00K |
| 548 | TOVX | Theriva Biologics, Inc. | 7.85M | 2.42% | 259,965 | - |
| 549 | IMRN | Immuron Limited | 7.84M | 0.84% | 1,051 | 4.78M |
| 550 | PCSA | Processa Pharmaceuticals, Inc. | 7.48M | -1.79% | 13,721 | - |
| 551 | GTBP | GT Biopharma, Inc. | 7.47M | 3.77% | 92,273 | - |
| 552 | GOVX | GeoVax Labs, Inc. | 7.39M | 3.86% | 130,906 | 3.35M |
| 553 | RNAZ | TransCode Therapeutics, Inc. | 7.13M | -2.93% | 206 | - |
| 554 | PPBT | Purple Biotech Ltd | 7.07M | 0.23% | 22,159 | - |
| 555 | BGMS | Bio Green Med Solution, Inc. | 7.06M | 5.11% | 1,501 | 81.00K |
| 556 | TCRT | Alaunos Therapeutics, Inc. | 7.05M | 0.32% | 216 | 6.00K |
| 557 | CYCN | Cyclerion Therapeutics, Inc. | 6.81M | 8.48% | 13,281 | 2.86M |
| 558 | ACXP | Acurx Pharmaceuticals, Inc. | 6.69M | -2.73% | 397 | - |
| 559 | SLXN | Silexion Therapeutics Corp | 6.69M | 0.94% | 4,540 | - |
| 560 | ADIL | Adial Pharmaceuticals, Inc. | 6.67M | -0.83% | 8,355 | - |
| 561 | APRE | Aprea Therapeutics, Inc. | 6.61M | - | 58 | 488.24K |
| 562 | XTLB | XTL Biopharmaceuticals Ltd. | 6.60M | -2.02% | 541 | 968.00K |
| 563 | PPCB | Propanc Biopharma, Inc. | 6.18M | - | 6,864 | - |
| 564 | CANF | Can-Fite BioPharma Ltd. | 5.67M | 1.21% | 4,369 | 560.00K |
| 565 | INDP | Indaptus Therapeutics, Inc. | 5.52M | 0.64% | 12,344 | - |
| 566 | SILO | Silo Pharma, Inc. | 5.23M | - | 1,698 | 72.10K |
| 567 | GNPX | Genprex, Inc. | 5.22M | 2.27% | 1,058,962 | - |
| 568 | VIVS | VivoSim Labs, Inc. | 5.19M | 3.65% | - | 140.00K |
| 569 | REVB | Revelation Biosciences, Inc. | 5.19M | -2.74% | 3,748 | - |
| 570 | DCOY | Decoy Therapeutics Inc. | 5.02M | -4.05% | 15,159 | - |
| 571 | XBIO | Xenetic Biosciences, Inc. | 4.97M | -1.63% | 656 | 2.86M |
| 572 | SPRC | SciSparc Ltd. | 4.75M | -0.68% | 4,517 | 1.31M |
| 573 | GLMD | Galmed Pharmaceuticals Ltd. | 4.66M | 1.99% | 2,817 | - |
| 574 | JAGX | Jaguar Health, Inc. | 4.63M | -2.86% | 22,312,261 | 11.79M |
| 575 | MTNB | Matinas BioPharma Holdings, Inc. | 4.12M | 0.02% | 1,135 | - |
| 576 | XRTX | XORTX Therapeutics Inc. | 4.01M | 1.54% | 2,077 | - |
| 577 | ENVB | Enveric Biosciences, Inc. | 3.94M | -2.78% | 1,752 | - |
| 578 | CNSP | CNS Pharmaceuticals, Inc. | 3.60M | -0.34% | 299 | - |
| 579 | ENSC | Ensysce Biosciences, Inc. | 3.55M | -4.25% | 22,127 | 4.49M |
| 580 | CDIO | Cardio Diagnostics Holdings, Inc. | 3.51M | -6.34% | 55,704 | 15.78K |
| 581 | LYRA | Lyra Therapeutics, Inc. | 3.48M | -47.97% | 458,994 | 600.00K |
| 582 | PHGE | BiomX Inc. | 3.47M | -0.44% | 4,311 | - |
| 583 | CMND | Clearmind Medicine Inc. | 3.39M | -3.83% | 2,074 | - |
| 584 | OGEN | Oragenics, Inc. | 3.30M | -4.70% | 272 | - |
| 585 | HCWB | HCW Biologics Inc. | 3.30M | - | 41,815 | 422.03K |
| 586 | AZTR | Azitra, Inc. | 3.08M | -0.97% | 342,916 | 7.50K |
| 587 | BBLG | Bone Biologics Corporation | 2.89M | -0.62% | 4,924 | - |
| 588 | ARTL | Artelo Biosciences, Inc. | 2.82M | -1.76% | 7,198 | - |
| 589 | VRAX | Virax Biolabs Group Limited | 2.78M | 3.59% | 9,945 | 2.99K |
| 590 | ONCO | Onconetix, Inc. | 2.67M | - | 104,268 | 1.22M |
| 591 | SCNI | Scinai Immunotherapeutics Ltd. | 2.63M | -0.38% | 31 | 1.15M |
| 592 | CDT | CDT Equity Inc. | 2.57M | -1.99% | 526 | - |
| 593 | DRMA | Dermata Therapeutics, Inc. | 2.41M | -1.44% | 5,281 | - |
| 594 | GRI | GRI Bio, Inc. | 2.30M | 0.89% | 253,654 | - |
| 595 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.28M | 2.56% | 83,365 | 1.36M |
| 596 | BDRX | Biodexa Pharmaceuticals Plc | 2.00M | 1.25% | 9,338 | 104.90K |
| 597 | PBM | Psyence Biomedical Ltd. | 1.53M | 2.10% | 124,886 | - |
| 598 | ADTX | Aditxt, Inc. | 1.39M | -1.25% | 29,704 | 5.95K |
| 599 | MLEC | Moolec Science SA | 1.13M | - | 495 | 7.83M |
| 600 | ELAB | PMGC Holdings Inc. | 985.96K | 0.95% | 61,864 | 285.95K |